Compare Bank Mayapada Internasional Tbk. (MAYA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank Mayapada Internasional Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Bank Mayapada Internasional Tbk. trades at Rp197 (market cap 5.08T, 476.3K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Bank Mayapada Internasional Tbk. is far larger — about 48.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MAYA | SCPI | |
|---|---|---|
Market Cap | 5.08T | 104.4B |
Volume | 476.3K | — |
Lot | 4.76K | — |
Turnover | 92.84M | — |
Average Price | 194.91 | — |
Value | 92.84M | — |
Indicative Equilibrium Price | 197 | — |
Indicative Equilibrium Volume | 17 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Mayapada Internasional Tbk.
PT. Bank Mayapada Tbk (the Company) was established based on Notarial Deed OF notary Edison Jingga, SH No 196 dated September 7, 1989 by the Notary Edison Jingga, SH., substitute for Misahardi Wilamarta, SH.By September 22, 1999 the bank increased its authorized capital from Rp 300,000,000,000 to Rp 650,000,000,000 which consits of 1,300,000,000 shares with nominal value of Rp 500 per share.
Read more on MAYA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
